In vivo engraftment of vascular structures in 3D-engineered artificial tissues vascularized by cord blood- or peripheral blood-derived endothelial colony-forming cells
Abstract
Constructing human vascularized artificial tissues (HVATs) that form stable vascular structures after transplantation remains challenging in regenerative medicine. Using the cryopreserved cell accumulation method (CP-CAM), a scaffold-free approach based on extracellular matrix nanofilm-coated cells, we generated HVATs from human adipose tissue-derived mesenchymal stromal cells (hASCs) and cord blood- or peripheral blood-derived endothelial colony-forming cells (hCB-ECFCs and hPB-ECFCs). Both ECFCs formed vascular networks within four days after seeding, with no significant differences in two-dimensional vascular length density or area fraction compared with HUVEC-based constructs. hCB-ECFC-derived vascular structures showed incomplete endothelial closure and reduced perivascular differentiation of hASCs in vitro, whereas hPB-ECFC-derived structures exhibited more continuous vascular morphology. Angiogenesis-related factor profiling of HVAT supernatants suggested distinct patterns among endothelial cell sources. After subcutaneous transplantation into nude mice, hCB-ECFC-derived vessels exhibited continuous endothelial lumens and surrounding pericyte- or smooth muscle-like cells, with further structural maturation over four weeks. HVATs constructed with hPB-ECFCs also engrafted and formed human-derived vascular structures containing host blood cells and surrounded by perivascular cells. These findings demonstrate that both hCB-ECFCs and hPB-ECFCs can be used to construct transplantable HVATs by CP-CAM and support the potential of blood-derived ECFCs as endothelial cell sources for vascularized tissue engineering and therapeutic applications.
Related
- Endothelial Network Formation Within Human Tissue-Engineered Skeletal Muscle
- Influence of dietary supplementation with French maritime pine bark extract (Pycnogenol®) on endothelial glycocalyx structures in a dynamic cell culture model
- 1121 Insights from orthotopic tumor engraftment in humanized mice
- Mast cells may promote myeloma engraftment in the NSG-hIL6 patient derived xenograft model
- Clinical Outcomes of Pedicled Vascularized Bone Grafting for Scaphoid Nonunion
BibTeX
@article{asano2026vivo,
title = {{In vivo engraftment of vascular structures in 3D-engineered artificial tissues vascularized by cord blood- or peripheral blood-derived endothelial colony-forming cells}},
author = {Yoshiya Asano and Yoshiko Tamai and Hiroshi Shimoda},
journal = {Scientific Reports},
year = {2026},
month = sep,
doi = {10.1038/s41598-026-73908-7},
url = {https://www.nature.com/articles/s41598-026-73908-7},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - In vivo engraftment of vascular structures in 3D-engineered artificial tissues vascularized by cord blood- or peripheral blood-derived endothelial colony-forming cells
AU - Yoshiya Asano
AU - Yoshiko Tamai
AU - Hiroshi Shimoda
PY - 2026
DA - 2026/09/30
JO - Scientific Reports
DO - 10.1038/s41598-026-73908-7
UR - https://www.nature.com/articles/s41598-026-73908-7
AB - Constructing human vascularized artificial tissues (HVATs) that form stable vascular structures after transplantation remains challenging in regenerative medicine. Using the cryopreserved cell accumulation method (CP-CAM), a scaffold-free approach based on extracellular matrix nanofilm-coated cells, we generated HVATs from human adipose tissue-derived mesenchymal stromal cells (hASCs) and cord blood- or peripheral blood-derived endothelial colony-forming cells (hCB-ECFCs and hPB-ECFCs). Both ECFCs formed vascular networks within four days after seeding, with no significant differences in two-dimensional vascular length density or area fraction compared with HUVEC-based constructs. hCB-ECFC-derived vascular structures showed incomplete endothelial closure and reduced perivascular differentiation of hASCs in vitro, whereas hPB-ECFC-derived structures exhibited more continuous vascular morphology. Angiogenesis-related factor profiling of HVAT supernatants suggested distinct patterns among endothelial cell sources. After subcutaneous transplantation into nude mice, hCB-ECFC-derived vessels exhibited continuous endothelial lumens and surrounding pericyte- or smooth muscle-like cells, with further structural maturation over four weeks. HVATs constructed with hPB-ECFCs also engrafted and formed human-derived vascular structures containing host blood cells and surrounded by perivascular cells. These findings demonstrate that both hCB-ECFCs and hPB-ECFCs can be used to construct transplantable HVATs by CP-CAM and support the potential of blood-derived ECFCs as endothelial cell sources for vascularized tissue engineering and therapeutic applications.
SN - 2045-2322
ER -